Scientists unveil PINK1 protein structure, paving way for Parkinson’s Disease therapies
HQ Team March 20, 2025: Scientists at the Walter and Eliza Hall Institute (WEHI, Australia) have uncovered the structure of the PINK1 protein.
Health
Research
Drugs
Research
Celon Pharmaās pill shows promise in reducing dyskinesia in Parkinsonās trial
HQ Team March 17, 2025: Celon Pharmaās human trial with PDE10A inhibitor, CPLā36, has achieved statistically significant reductions in involuntary movements caused by.
Health
Research
MITās 40Hz gamma stimulation shows promise in slowing Alzheimerās progression
HQ Team March 15, 2025: A decade of research at MITās Picower Institute for Learning and Memory has brought hope to millions battling.
Health
Research
Parkinson’s Disease cases to hit 25 million worldwide by 2050
HQ Team March 10, 2025: A recent study published in The BMJ forecasts a significant rise in Parkinson’s disease cases globally, with projections.
Health
Medical
Pharma
Medtronic Plc’s neurostimulator for Parkinson’s gets USFDA approval
Irelandās Medtronic Plcās deep brain stimulation device for patients with Parkinsonās disease has been approved by the US Food and Drug Administration, according.
Drugs
Health
Medical
Supernusā injection to treat advanced Parkinsonās gets US regulatorās nod
Supernus Pharmaceuticals Incās injection for treating people with advanced Parkinsonās disease got a green light from the US regulator after two earlier rejections.
Drugs
Health
Research
Cambridge researchers making brain implants to treat Parkinsonās
Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinsonās.
Drugs
Health
Medical
Dancing can help lower depression in people with Parkinsonās disease
Dancing has a positive effect on the āmood circuitsā in the brain and can lower depression in people with Parkinsonās disease, according to.
Health
Research
Research identifies RNA structures linked to Parkinson’s
HQ Team November 20, 2024: A team of researchers from Kumamoto University has found that unique RNA structures known as G-quadruplexes (G4s) facilitate.
Drugs
Medical
Pharma
FDA approves AbbVieās new drug for advanced Parkinsonās disease
HQ Team October 19, 2024: The U.S. Food and Drug Administration (FDA) has approved AbbVeiās drug Vyalev for the treatment of advanced Parkinson’s.